glp-1 for ckd receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease CKJ REVIEW GLP-1 receptor agonists
Description
Since the glucose-lowering effects of GIP have been shown to be impaired in patients with T2D, interest has focused on developing antidiabetic therapies based upon the actions of GLP-1 and GIP, the response to which remains intact. To continue reading Log in or register to continue reading
Kalra S
For Akin, the weekly injections have been transformative
GLP-1 Receptor Agonists: A Promising Therapy for Modern Lifestyle Diseases with Unforeseen Challenges
[DOI] [Google Scholar] 47.Dutta P., Kumar Y., Babu A
Many studies have found no significant changes in basal or stimulated cortisol levels with GLP-1 therapy
